You are here: All Products  > Evive Sells US Rights for Neutropenia Therapy to Aerotech in $236.5 Million Deal

Evive Sells US Rights for Neutropenia Therapy to Aerotech in $236.5 Million Deal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products